MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
$18,465K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from term loans
Share-based compensation
Accrued expenses
Others
Negative Cash Flow Breakdown
Repurchase of ripsa
Accounts receivable
Income taxes
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2025-06-30
Tax incentive receivable
-1,874
Operating lease liabilities
-421
Royalties payable
1,988
Share-based compensation
72,291
Net income/(loss)
-4,398
Prepaid expenses
3,859
Other current liabilities
-2,488
Other current assets
572
Inventory
6,301
Income taxes
-9,454
Accrued expenses
27,106
Accounts receivable
51,362
Accounts payable
-7,832
Loss on extinguishment of debt
-407
Foreign exchange (gain)/loss
1,567
Depreciation
588
Amortization of debt issuance costs
1,346
Accretion of redemption premium on debt
0
Accretion of ripsa
1,654
Net cash provided by/(used in) operating activities
19,000
Purchases of furniture and equipment
535
Net cash used in investing activities
-535
Repurchase of ripsa
109,921
Proceeds from ripsa
0
Repayment of 2023 term loans
0
Proceeds from exercise of share options
10,108
Proceeds from term loans
122,500
Payments of withholding taxes from share-based awards
4,287
Payment of debt issuance costs
0
Net cash provided by financing activities
18,400
Effect of exchange rate changes on cash and cash equivalents
1,394
Net change in cash and cash equivalents
38,259
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Share-based compensation
$72,291K
Proceeds from term loans
$122,500K
Accrued expenses
$27,106K
Royalties payable
$1,988K
Tax incentive
receivable
-$1,874K
Accretion of ripsa
$1,654K
Amortization of debt issuance
costs
$1,346K
Depreciation
$588K
Loss on
extinguishment of debt
-$407K
Proceeds from exercise of
share options
$10,108K
Net cash provided
by/(used in) operating...
$19,000K
Net cash provided by
financing activities
$18,400K
Effect of exchange rate
changes on cash and cash...
$1,394K
Canceled cashflow
$88,254K
Canceled cashflow
$114,208K
Net change in cash
and cash...
$38,259K
Canceled cashflow
$535K
Accounts receivable
$51,362K
Income taxes
-$9,454K
Accounts payable
-$7,832K
Inventory
$6,301K
Net income/(loss)
-$4,398K
Prepaid expenses
$3,859K
Other current
liabilities
-$2,488K
Foreign exchange
(gain)/loss
$1,567K
Other current assets
$572K
Operating lease
liabilities
-$421K
Repurchase of ripsa
$109,921K
Payments of withholding
taxes from...
$4,287K
Net cash used in
investing activities
-$535K
Purchases of furniture and
equipment
$535K
Buy us a coffee
Verona Pharma plc (VRNA)
Verona Pharma plc (VRNA)